S&P 500   3,973.75 (+1.86%)
DOW   31,880.24 (+1.98%)
QQQ   293.48 (+1.66%)
AAPL   143.11 (+4.01%)
MSFT   260.65 (+3.20%)
FB   196.23 (+1.39%)
GOOGL   2,229.76 (+2.37%)
AMZN   2,151.14 (-0.03%)
TSLA   674.90 (+1.66%)
NVDA   168.98 (+1.22%)
BABA   87.23 (+0.51%)
NIO   16.00 (-2.68%)
AMD   95.07 (+1.68%)
CGC   5.19 (-5.98%)
MU   69.59 (+1.00%)
T   20.74 (+1.67%)
GE   75.46 (+0.28%)
F   12.83 (+2.64%)
DIS   105.83 (+3.33%)
AMC   11.58 (-3.74%)
PFE   52.88 (+0.78%)
PYPL   81.18 (+0.79%)
NFLX   187.44 (+0.58%)
S&P 500   3,973.75 (+1.86%)
DOW   31,880.24 (+1.98%)
QQQ   293.48 (+1.66%)
AAPL   143.11 (+4.01%)
MSFT   260.65 (+3.20%)
FB   196.23 (+1.39%)
GOOGL   2,229.76 (+2.37%)
AMZN   2,151.14 (-0.03%)
TSLA   674.90 (+1.66%)
NVDA   168.98 (+1.22%)
BABA   87.23 (+0.51%)
NIO   16.00 (-2.68%)
AMD   95.07 (+1.68%)
CGC   5.19 (-5.98%)
MU   69.59 (+1.00%)
T   20.74 (+1.67%)
GE   75.46 (+0.28%)
F   12.83 (+2.64%)
DIS   105.83 (+3.33%)
AMC   11.58 (-3.74%)
PFE   52.88 (+0.78%)
PYPL   81.18 (+0.79%)
NFLX   187.44 (+0.58%)
S&P 500   3,973.75 (+1.86%)
DOW   31,880.24 (+1.98%)
QQQ   293.48 (+1.66%)
AAPL   143.11 (+4.01%)
MSFT   260.65 (+3.20%)
FB   196.23 (+1.39%)
GOOGL   2,229.76 (+2.37%)
AMZN   2,151.14 (-0.03%)
TSLA   674.90 (+1.66%)
NVDA   168.98 (+1.22%)
BABA   87.23 (+0.51%)
NIO   16.00 (-2.68%)
AMD   95.07 (+1.68%)
CGC   5.19 (-5.98%)
MU   69.59 (+1.00%)
T   20.74 (+1.67%)
GE   75.46 (+0.28%)
F   12.83 (+2.64%)
DIS   105.83 (+3.33%)
AMC   11.58 (-3.74%)
PFE   52.88 (+0.78%)
PYPL   81.18 (+0.79%)
NFLX   187.44 (+0.58%)
S&P 500   3,973.75 (+1.86%)
DOW   31,880.24 (+1.98%)
QQQ   293.48 (+1.66%)
AAPL   143.11 (+4.01%)
MSFT   260.65 (+3.20%)
FB   196.23 (+1.39%)
GOOGL   2,229.76 (+2.37%)
AMZN   2,151.14 (-0.03%)
TSLA   674.90 (+1.66%)
NVDA   168.98 (+1.22%)
BABA   87.23 (+0.51%)
NIO   16.00 (-2.68%)
AMD   95.07 (+1.68%)
CGC   5.19 (-5.98%)
MU   69.59 (+1.00%)
T   20.74 (+1.67%)
GE   75.46 (+0.28%)
F   12.83 (+2.64%)
DIS   105.83 (+3.33%)
AMC   11.58 (-3.74%)
PFE   52.88 (+0.78%)
PYPL   81.18 (+0.79%)
NFLX   187.44 (+0.58%)
NASDAQ:CELU

Celularity News Headlines

$7.10
-0.36 (-4.83%)
(As of 05/23/2022 04:00 PM ET)
Add
Compare
Today's Range
$7.10
$7.88
50-Day Range
$5.77
$12.91
52-Week Range
$3.63
$13.40
Volume
330,835 shs
Average Volume
270,448 shs
Market Capitalization
$977.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
-0.4
Get Celularity News Delivered to You Automatically

Sign up to receive the latest news and ratings for CELU and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Celularity Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CELU
News Sentiment

-0.31

0.30

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CELU Articles
This Week

11

1

CELU Articles
Average Week



Celularity (NASDAQ:CELU) News Headlines Today

SourceHeadline
marketbeat.com logoOppenheimer Comments on Celularity Inc.'s FY2022 Earnings (NASDAQ:CELU)
marketbeat.com - May 19 at 6:44 AM
MarketBeat logoFY2022 Earnings Estimate for Celularity Inc. (NASDAQ:CELU) Issued By Oppenheimer
americanbankingnews.com - May 20 at 2:24 AM
globenewswire.com logoCelularity Inc. Announces $30 Million Private Placement Priced At-The-Market Under Nasdaq Rules - GlobeNewswire
globenewswire.com - May 18 at 6:31 PM
finance.yahoo.com logoCelularity Inc. Announces $30 Million Private Placement Priced At-The-Market Under Nasdaq Rules
finance.yahoo.com - May 18 at 6:31 PM
finance.yahoo.com logoCelularity Reports First Quarter 2022 Financial Results and Provides Corporate Update - Yahoo Finance
finance.yahoo.com - May 16 at 8:41 PM
finance.yahoo.com logoCelularity Reports First Quarter 2022 Financial Results and Provides Corporate Update
finance.yahoo.com - May 16 at 8:41 PM
MarketBeat logoCelularity (NASDAQ:CELU) Shares Gap Up to $5.77
americanbankingnews.com - May 15 at 1:42 AM
MarketBeat logoHead-To-Head Contrast: Lyell Immunopharma (NASDAQ:LYEL) versus Celularity (NASDAQ:CELU)
americanbankingnews.com - May 14 at 1:34 AM
seekingalpha.com logoInotiv, TScan Therapeutics top healthcare gainers; Opiant, Renovacor lead losers' pack - Seeking Alpha
seekingalpha.com - May 13 at 1:04 PM
benzinga.com logoThinking about buying stock in Affirm Holdings, Celularity, Robinhood Markets, Endeavor Group, or Toast? - Benzinga
benzinga.com - May 13 at 1:04 PM
businesswire.com logoGlobal Amniotic Membrane Market (2022 to 2028) - Potential Use in Tissue Engineering Applications Presents Opportunities - ResearchAndMarkets.com - Business Wire
businesswire.com - May 12 at 3:00 PM
benzinga.com logoCelularity Says On April 29 Received Email Notification From FDA Regarding CYCART-19 IND; FDA Says It Wil - Benzinga
benzinga.com - May 3 at 10:35 PM
MarketBeat logoCelularity (NASDAQ:CELU) Shares Gap Down to $12.91
americanbankingnews.com - May 1 at 2:22 AM
uk.finance.yahoo.com logoCelularity Inc. (CELU)
uk.finance.yahoo.com - April 30 at 12:05 AM
seekingalpha.com logoCelularity: Funds Infusion Needed ASAP To Advance
seekingalpha.com - April 26 at 1:30 PM
benzinga.com logoTruist Securities Downgrades Celularity to Hold
benzinga.com - April 6 at 11:28 AM
seekingalpha.com logoCelularity GAAP EPS of -$0.03, revenue of $4.86M
seekingalpha.com - March 31 at 9:59 PM
finance.yahoo.com logoCelularity Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
finance.yahoo.com - March 31 at 4:59 PM
marketwatch.com logoAdvanced Wound Care Market Report Analysis, Share, Revenue, Growth Rate With Forecast Overview To 2028
marketwatch.com - March 30 at 8:53 PM
nz.finance.yahoo.com logoBioactive Materials Market is Likely to Expand at a Projected CAGR of 11.3% during by 2032- Exclusive Report by Fact.MR
nz.finance.yahoo.com - March 25 at 2:03 AM
tmcnet.com logoScilex Holding Company, a Majority-Owned Subsidiary of
tmcnet.com - March 17 at 5:47 PM
finance.yahoo.com logoWhat Percentage Of Celularity Inc. (NASDAQ:CELU) Shares Do Insiders Own?
finance.yahoo.com - March 15 at 5:39 PM
finance.yahoo.com logoCelularity to Present at Oppenheimer 32nd Annual Healthcare Conference
finance.yahoo.com - March 15 at 5:39 PM
sg.finance.yahoo.com logoPerrigo (PRGO) Q4 Earnings Beat as Cough & Cold Sales Recover
sg.finance.yahoo.com - March 8 at 1:48 PM
finance.yahoo.com logoCelularity Receives Orphan Drug Designation from U.S. FDA for its NK Cell Therapy CYNK-101 in Development for the First-Line Treatment of Advanced HER2/neu Positive Gastric and Gastroesophageal Junction Cancers
finance.yahoo.com - February 15 at 7:34 PM
nasdaq.com logoIs Celularity, Inc. (CELU) Outperforming Other Medical Stocks This Year?
nasdaq.com - February 11 at 11:51 AM
benzinga.com logoOppenheimer Initiates Coverage On Celularity with Outperform Rating, Announces Price Target of $9
benzinga.com - January 28 at 9:43 AM
finance.yahoo.com logoStarr International Co Inc Buys Celularity Inc, Sells Moderna Inc, AstraZeneca PLC, Johnson ...
finance.yahoo.com - January 27 at 8:21 PM
finance.yahoo.com logoC V Starr & Co Inc Buys Celularity Inc
finance.yahoo.com - January 27 at 8:21 PM
seekingalpha.com logoCelularity falls 7% despite FDA fast track status for CYNK-101 in gastric cancers
seekingalpha.com - January 18 at 4:21 PM
finance.yahoo.com logoCelularity Receives Fast Track Designation from U.S. FDA for its NK Cell Therapy CYNK-101 in Development for the First-Line Treatment of Advanced HER2/neu Positive Gastric and Gastroesophageal Junction Cancers
finance.yahoo.com - January 18 at 11:20 AM
nasdaq.com logoCelularity Inc - Class A Shares Approach 52-Week Low - Market Mover
nasdaq.com - January 13 at 8:35 AM
finance.yahoo.com logoCelularity Receives Fast Track Designation from U.S. FDA for its NK Cell Therapy CYNK-001 in Development for the Treatment of AML
finance.yahoo.com - December 27 at 10:07 AM
finance.yahoo.com logoAnalysts' Revenue Estimates For Celularity Inc. (NASDAQ:CELU) Are Surging Higher
finance.yahoo.com - December 15 at 2:25 PM
benzinga.com logoCelularity Presents Preclinical Data On Allogeneic Genetically Modified Natural Killer And Allogeneic CAR-NK Cell Therapy Programs At ASH 2021
benzinga.com - December 13 at 12:02 PM
finance.yahoo.com logoCelularity Presents Preclinical Data on Allogeneic Genetically Modified Natural Killer (NK) and Allogeneic CAR-NK Cell Therapy Programs at the 63rd American Society of Hematology Meeting and Exposition
finance.yahoo.com - December 13 at 12:02 PM
finance.yahoo.com logoCelularity Announces FDA Clearance of Investigational New Drug Application (IND) for Natural Killer Cell Therapy CYNK-101 in First-line Advanced Her2/neu Positive Gastric and Gastroesophageal Junction Cancer
finance.yahoo.com - November 29 at 8:31 AM
finance.yahoo.com logoCelularity (NASDAQ:CELU) investors are sitting on a loss of 34% if they invested a year ago
finance.yahoo.com - November 16 at 8:51 AM
finance.yahoo.com logoCelularity Presents Preclinical Data on Allogeneic Genetically-Modified Natural Killer Cells at the Society for Immunotherapy of Cancer 36th Annual Meeting
finance.yahoo.com - November 15 at 12:19 PM
finance.yahoo.com logoCelularity Reports Third Quarter 2021 Financial Results and Corporate Update
finance.yahoo.com - November 12 at 5:59 PM
msn.com logoCramer's lightning round: I like Blade Air Mobility over Joby Aviation
msn.com - September 21 at 11:43 PM
marketwatch.com logoCelularity Hires Andrew Pecora as President
marketwatch.com - September 16 at 9:14 PM
finance.yahoo.com logoCelularity Appoints Andrew L. Pecora, M.D., F.A.C.P., C.P.E., as President
finance.yahoo.com - September 16 at 9:14 PM
msn.com logoThe Genius Behind Palantir's SPAC Investments
msn.com - August 29 at 4:55 PM
markets.businessinsider.com logoGT Biopharma Announces the Promotion of Dr. Gregory Berk to President of Research & Development and Chief Medical Officer
markets.businessinsider.com - August 23 at 9:30 AM
au.finance.yahoo.com logoCelularity Reports Second Quarter 2021 Financial Results
au.finance.yahoo.com - August 16 at 5:22 PM
msn.com logoGenting Bhd's biotechnology arm strikes partnership with Australia-listed firm
msn.com - August 6 at 3:56 AM
msn.com logoWhy the Imugene (ASX:IMU) share price is charging higher on Thursday
msn.com - August 4 at 8:22 PM
nasdaq.com logoCelularity Inc. Warrant (CELUW)
nasdaq.com - August 2 at 5:50 PM
barrons.com logoCelularity Inc. Wt
barrons.com - July 26 at 12:02 AM
wsj.com logoCelularity Inc.
wsj.com - July 23 at 11:00 PM
Get Celularity News Delivered to You Automatically

Sign up to receive the latest news and ratings for CELU and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 5/23/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.